Latest news

Filter News Articles

Conditions






Topics





















European Medicines Agency (EMA) - Review underway for MS Drug Lemtrada®

Following a warning late last year, European neurologists have been cautioned on the use of the MS treatment Lemtrada; while the EMA undertakes their review of side effects in some European patients.

MSWA uniting the community to support people living with Parkinson’s Disease

MSWA is proud to continue its commitment to raising awareness of Parkinson’s.

Read how MSWA is supporting Western Australians who have been touched by the condition.

MSWA & WASO connecting young West Australians to healthy brain stimulation

Young people in Western Australia will have greater access to the proven benefits of classical music, thanks to our partnership with the West Australian Symphony Orchestra (WASO).

MSWA Funded Brain Plasticity Research Offers Hope for Neurological Conditions

Using brain plasticity to repair a damaged brain is the underlying goal of research undertaken by Perron Institute researcher Associate Professor Jenny Rodger.

Scientists seek evidence about diet and progression of MS

Can diet affect multiple sclerosis? Dr Lucinda Black, MSWA funded researcher shares her latest research into patterns between the intake of specific foods and nutrients, and whether they contribute to the risk of MS.

WASO announces unique partnership with MSWA

MSWA is thrilled to announce our involvement with the West Australian Symphony Orchestra for their 2019 season. This partnership recognises a shared commitment to enriching the lives of young people and families through music.

New home soon for Kate in Butler

In 2005, Kate Gild was diagnosed with multiple sclerosis (MS) when she was 33-years-old. She was living in London at the time and home in Perth on holiday visiting family, when she started experiencing nerve pain in her wrist. Kate thought it was Carpal tunnel, but an MRI revealed it was MS.

MAVENCLAD® (cladribine tablets) for RRMS Australian Government approves PBS listing
Australian AHSCT Trial Results Released

Results into an Australian study of the treatment autologous haematopoietic stem cell therapy (AHSCT) were released earlier this week.

Read more

New premises in Belmont for MSWA in 2019

As MSWA continues to support people living with all neurological conditions, the need for a more tailored and larger premises has been welcomed by the MSWA community, which benefits from receiving support from over 750 staff within the organisation.

Read more